
Titan Pharmaceuticals TTNP
Quarterly report 2025-Q2
added 08-14-2025
Titan Pharmaceuticals P/S Ratio 2011-2026 | TTNP
Annual P/S Ratio Titan Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.4 | 0.929 | 6.63 | 2.13 | 1.72 | 2.43 | 133 | 5.58 | 42.4 | 12.4 | 5.67 | 17.3 | 17.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 133 | 0.929 | 21.2 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 234.99 | 0.02 % | $ 5 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
AC Immune SA
ACIU
|
35 | $ 2.72 | 7.51 % | $ 229 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.81 | 1.28 % | $ 4.42 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
argenx SE
ARGX
|
311 | $ 840.28 | 1.7 % | $ 25 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.33 | 0.79 % | $ 8.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Atea Pharmaceuticals
AVIR
|
2.11 | $ 4.65 | 1.31 % | $ 392 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Axsome Therapeutics
AXSM
|
13.6 | $ 169.95 | -2.75 % | $ 8.45 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
2.97 | $ 195.13 | -0.62 % | $ 28.6 B | ||
|
BioMarin Pharmaceutical
BMRN
|
4.6 | $ 62.62 | -0.48 % | $ 11.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
0.614 | - | 0.59 % | $ 63 K | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 110.89 | 0.87 % | $ 27.2 B | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 14.66 | 1.66 % | $ 4.53 B | ||
|
Capricor Therapeutics
CAPR
|
6.17 | $ 27.91 | 0.14 % | $ 747 M | ||
|
CASI Pharmaceuticals
CASI
|
36.1 | $ 0.8 | 5.68 % | $ 109 M |